Since tau aggregations have been described to be associated with WM microstructural alterations in Alzheimer’s disease [45, 46], the tau-pathology could be also related to a pronounced FA decrease in DM1 leading to a widespread impact on several brain structures. The gene discussed is MAPT; the disease is Alzheimer disease.